|
|
 |
 |
|
| |
 |
|
|
| ¹Ú Á¾ ¼· ±³¼ö (Jong Sup Park, MD., Professor) |
|
|
|
±³À° ÀÌ·Â
Education
|
|
|
- °æ±â°íµîÇб³ (Kyunggy High School, Seoul) 1969-1972
- °¡Å縯Àǰú´ëÇÐ (Catholic University Medical College, Seoul (B.A.)) 1978
- °¡Å縯Áß¾ÓÀÇ·á¿ø
- ÀÎÅÏ (Rotating Internship, Catholic Medical Center, Seoul) 1978-1979 - ·¹Áö´øÆ® (Residency, Department of Obstetrics and Gynecology, Catholic Medical Center, Seoul) 1979-1983
- °¡Å縯Àǰú´ëÇÐ ´ëÇпø ÀÇÇм®»ç (Postgraduate School, Catholic University Medical College, Seoul (M.S. of Med. Science) 1981
- °¡Å縯Àǰú´ëÇÐ ´ëÇпø ÀÇÇйڻç (Postgraduate School, Catholic University Medical College, Seoul (Dr. of Med. Science) 1985
|
|
|
¸éÇãÁõ
Licenses
|
|
|
- ÀÇ»ç¸éÇãÁõ (Korean Medical Doctor - No.10751)
- Àü¹®ÀÇ ÀÚ°ÝÁõ (Korean Board of Obstetrics and Gynecology - No. 451)
|
|
|
¹æ¼Û Ã⿬
|
|
|
- 2004.01.29. MBC Çູ ½Ç¼ÓÁ¤º¸ (ÀÚ±ÃÁúȯ)
- 2004.8.31. KBS: ¹«¾ùÀÌµç ¹°¾îº¸¼¼¿ä. (ÀڱðæºÎ¾Ï)
- 2004.9.7. KBS: ¹«¾ùÀÌµç ¹°¾îº¸¼¼¿ä. (ÀڱñÙÁ¾)
- 2005.06.24. MBC Á¤º¸Æ¯±Þ ¾ÏÁ¤º¹ ½Ã¸®Áî; ³¼Ò¾Ï
- 2005.11.11. MBC News Time ÀڱðæºÎ¾Ï Á¶±â °ËÁø
- 2005.11.13. KBS 2: Vitamin
|
|
|
½Å¹®º¸µµÀÚ·á
Newspaper
|
|
|
- 2004.2.17. ±¹¹ÎÀϺ¸ Á¦¸ñ: ÀڱðæºÎ¾Ï
- 2004.7.12. Áß¾ÓÀϺ¸ Á¦¸ñ: ÀڱðæºÎ¾Ï
- 2004.7. Çѱ¹Èº¸; ¿©¼º ÁúȯÀÇ ¿øÀΰú ¿¹¹æ
- 2004.7.20 Áß¾ÓÀϺ¸: HPV DNA chip ½Ä¾àû Çã°¡ Ãëµæ
- 2004.08.30. Çѱ¹ÀϺ¸; ÀڱðæºÎ¾Ï, ¼º °æÇè ³ªÀÌ ¾î¸±¼ö·Ï À§Çè
- 2005. 4 ¿ùÈ£ ¿©¼ºµ¿¾Æ
- 2005. 4 ¿ùÈ£ Queen
- 2005.05.23 µ¿¾ÆÀϺ¸; ¾Ï ¿¹¹æ Áöħ
|
|
|
°æ·Â
Present and Recent Positions
|
|
|
- ±ºÀǰü (Korean Army Surgeon) 1983-1986
- °¡Å縯Àǰú´ëÇÐ (Department of Obstetrics and Gynecology, Catholic University Medical College, Seoul)
- ÀüÀÓ°»ç (Instructor) 1986-1989 - Á¶±³¼ö (Assistant Professor) 1990-1993 - ºÎ±³¼ö (Associate Professor) 1994-1997 - ±³¼ö (Professor) 1998-ÇöÀç
- °»ç (Johns Hopkins University, School of Medicine, Research Fellow) 1989-1990
- ±³È¯±³¼ö (Johns Hopkins University, School of Medicine, Research Associate ) 1990-1991
- °¡Å縯ÀÇ´ë °³²¼º¸ðº´¿ø »êºÎÀΰú °úÀå
(Director, Department of Obstetrics and Gynecology, Kangnam St.Mary,s Hospital, Catholic Medical Center, Seoul) 2005.9 - 2009.1
- °¡Å縯 ¾Ï¼¾ÅÍ ¿¬±¸ºÎÀå, ºÎÀÎ¾Ï ¼¾ÅÍÀå
|
|
|
Àü¹®È°µ¿ºÐ¾ß
Professional Society and Committee
|
|
|
- ´ëÇѾÏÇÐȸ »óÀÓÀÌ»ç, È«º¸À§¿øÀå
- ´ëÇÑÀÇÇÐȸ ÇмúÀ§¿ø, °Ç°ÀÚ·á½ÉÀÇÀ§¿øÈ¸ ½ÉÀÇÀ§¿ø
- ´ëÇÑÀÇÇÐÇѸ²È¸ Á¤È¸¿ø
- Çѱ¹°úÇбâ¼ú ÃÑ¿¬ÇÕȸ ÀÌ»ç
- ¹Ì±¹¾ÏÇÐȸ : AACR(American Association of Cancer Research) Á¤È¸¿ø
- ¼¼°èºÎÀÎÁ¾¾çÇÐȸ Á¤È¸¿ø
- ´ëÇѺÎÀÎÁ¾¾çÇÐȸ ¿¬±¸¼ÒÀ§¿øÈ¸ À§¿øÀå, ÇмúÀ§¿ø, ÀÌ»ç
- SRC ¾ÏÀüÀÌ¿¬±¸¼Ò ¿î¿µÀ§¿ø
- °¡Å縯Àǰú´ëÇб³ »êºÎÀΰúÇб³½Ç ºÎÀÎÁ¾¾çÇÐ ºÐ°úÀå
- ÀÇÇùÁ¾ÇÕÇмú´ëȸ ÁøÇàºÐ°úÀ§¿øÀå
- ´ëÇÑ»êºÎÀΰúÇÐȸ ±âȹÀ§¿øÈ¸ À§¿ø
- ¾Æ½Ã¾Æ ¿À¼¼¾Æ´Ï¾Æ »êºÎÀΰúÇмú´ëȸ ÇмúÀ§¿øÈ¸ Á¾¾çºÐ°úÀ§¿øÀå, ºÎÀ§¿øÀå
- °¡Å縯´ëÇб³ ¼ºÀDZ³Á¤ ´ëÇпø Çл翬±¸È¸ À§¿ø
- °³²¼º¸ðº´¿ø °¨¿°À§¿øÈ¸ À§¿ø
- °³²¼º¸ðº´¿ø ¼öÇ÷À§¿øÈ¸ À§¿ø
- °³²¼º¸ðº´¿ø °¡Á¤°£È£ ÀÚ¹®À§¿øÈ¸ À§¿ø
- °¡Å縯´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ¿¬±¸À§¿øÈ¸ À§¿ø
- º¸°Çº¹ÁöºÎ ¿¹¹æÁ¢Á¾À§¿øÈ¸ ÆÄÇʷθ¶¹ÙÀÌ·¯½º ºÐ°úÀ§¿ø
- °¡Å縯Áß¾ÓÀÇ·á¿ø »õ º´¿ø °Ç¸³ ÃßÁøÀ§¿øÈ¸ À§¿ø
- °¡Å縯Áß¾ÓÀÇ·á¿ø »õ º´¿ø °Ç¸³ ¿©¼ºÀÇÇм¾ÅÍ À§¿øÀå
- Ä¡·á¹é½Å¿¬±¸È¸ ȸÀå
- IGCS (International Gynecological Cancer Society) Á¤È¸¿ø
- International Papillomavirus Society Á¤È¸¿ø
- °Ç°º¸Çè ½É»çÆò°¡¿ø Áø·á½É»çÆò°¡À§¿øÈ¸ Á߾ӽɻçÀ§¿øÈ¸ ºñ»ó±Ù½É»çÀ§¿ø
- Á¦ 31 Â÷ ÀÇÇùÁ¾ÇÕÇмú´ëȸ ÁøÇàºÐ°úÀ§¿øÀå
- ¾ÏÁ¤º¹À§¿øÈ¸ ±âȹÀ§¿ø
- Àǰú´ëÇÐ °³±³ 50 Áֳ⠱â³äÇмú´ëȸ ÇмúºÎÀ§¿øÀå
- °³²¼º¸ðº´¿ø ¾Ï¼¾ÅÍ °æ¿µ¹ßÀü TFT À§¿øÀå
- °³²¼º¸ðº´¿ø ÀÇ·á±âÀÚÀçÀ§¿ø, ¾à»ç½ÉÀÇÀ§¿ø, Ç×¾ÏÁ¦ ½ÉÀÇÀ§¿ø
- KBS ÀÇ·áÀÚ¹®À§¿ø
- °¡Å縯Áß¾ÓÀÇ·á¿ø »õ º´¿ø °Ç¸³ ¿©¼º¾Ï¼¾ÅÍ TFT À§¿øÀå
- °¡Å縯´ëÇб³ Àǰú´ëÇРƯ¼ºÈ »ç¾÷ ÃßÁø´Ü ±âȹ¿î¿µÀ§¿ø
- AOGIN (Asia-Oceania Research on Genital Infections and cervical Neoplasia) »óÀÓÀÌ»ç, Â÷±â ȸÀå
- GSK, Interantional Advisory Board Member
- MSD, Interantional Advisory Board Member
|
|
|
¼ö»ó °æ·Â
|
|
|
- Æ÷»ó 1992 °¡Å縯´ëÇпø ´ëÇпøÇмú»ó
- Æ÷»ó 1993 AOFOG Young Scientist Award ¾Æ½Ã¾Æ ¿À¼¼¾Æ´Ï¾Æ »êºÎÀΰúÇÐȸ
- Æ÷»ó 1995 ÀϺ»»êºÎÀΰúÇÐȸ Çмú»ó
- Æ÷»ó 1997 ¼¿ï½ÃÀÇ»çȸ À¯ÇÑÀÇÇÐ»ó °ø·Î»ó
- Æ÷»ó 1999 ´ëÇѾÏÇÐȸ Çмú»ó
- Æ÷»ó 1999 ´ëÇÑ»êºÎÀΰúÇÐȸ ÃÖ¿ì¼ö³í¹®»ó
- Æ÷»ó 2001 ¼¿ï½ÃÀÇ»çȸ À¯ÇÑÀÇÇлó ´ë»ó
- Æ÷»ó 2001 ÀϺ»»êºÎÀΰúÇÐȸ ±¹Á¦Çмú»ó
- Æ÷»ó 2003 Çѱ¹°úÇÐÀç´Ü 30 ´ë ¿ì¼ö¿¬±¸¼º°ú
- Æ÷»ó 2003 Çѱ¹°úÇбâ¼úÃÑ¿¬ÇÕȸ Á¦ 13 ȸ °úÇбâ¼ú¿ì¼ö³í¹®»ó
- 200604 ±¹³»Çмú»ó¼ö»ó ¹ÚÁ¾¼·°¡Å縯´ëÇб³(¼ºÀÇ) ´ëÇѺÎÀÎÁ¾¾çÄÝÆ÷½ºÇÇÇÐȸ´ëÇѹα¹(Çѱ¹) The mechanism of apoptotic and non-apoptotic programmed cell death (autophagy) in
|
|
|
±¹³» ÇмúÁö ³í¹® ¹ßÇ¥
Domestic Publications
|
|
|
- ±è ÂùÁÖ, ¹Ú ÅÂö, ¹Ú Á¾¼·, ÀÌ Áظð, ±è ½ÂÁ¶, ³²±Ã ¼ºÀº. AGUS ¼¼Æ÷ÁøÀ» °¡Áø ¿©¼ºÀÇ Æò°¡¿¡¼ HPV testÀÇ ÀÇÀÇ. ´ëÇÑ»êºÎȸÁö 43:1154-1161 (2000)
- ±è Å¿¬, ±è ÂùÁÖ, ±è ÀºÁÖ, ¹Ú ÅÂö, ³²±Ã ¼ºÀº, ¹Ú Àç°©, ¾ö ¼öÁ¾, ¹Ú Á¾¼·. ÀڱðæºÎ¾Ï ¼¼Æ÷ÁÖÀÇ HPV-URR º¯ÀÌ »óÅ¿¡ µû¸¥ Interferon/Retinoic acidÀÇ È¿°ú ºÐ¼®. ´ëÇѾÏÇÐȸÁö 32: 884-894 (2000)
- °í ¿µ¹Ì, ¹Ú Á¾¼·, ³²±Ã ¼ºÀº, ÀÌ ¼Ò¿µ, ±è ¼ö¾Æ, È« °æÀÚ, ¾ö ¼öÁ¾. AP-1ÀÇ ºÒȰ¼ºÈ¿¡ ÀÇÇÑ retinoid À¯µµÃ¼ÀÇ ³¼Ò¾Ï ¼ºÀå¾ïÁ¦. ´ëÇѾÏÇÐȸ 32: 1043-1049 (2000)
- ÀÌ ¿ë¼®, ±è ÂùÁÖ, ¹è Å¿í, ÃÖ ¼º±Ç, ¼Û ¹Î°æ, ¹Ú ÅÂö, ¹Ú Á¾¼·, ³²±Ã ¼ºÀº. ÀڱðæºÎ Àü¾Ï º´º¯ÀÇ Ä¡·áÈÄ ÃßÀû °üÂû¿¡ ÀÖ¾î¼ ÀÎÀ¯µÎÁ¾ ¹ÙÀÌ·¯½º °Ë»çÀÇ ÀÇÀÇ. ´ëÇѺÎÀÎÁ¾¾ç. ÄÝÆ÷ÇÐȸÁö 12: 195-202 (2001)
- ¹Ú µ¿Ãá, À¯ ¿µ¿Á, ÀÌ Çü±Ù, Á¤ ´ë¿µ, ±è ÀçÈÆ, ¹Ú Á¾¼·, ±è ´ëÈÆ, ³²±Ã ¼ºÀº. ÀڱðæºÎ¾Ï¿¡¼ Matrix Metalloproteinase-2ÀÇ Á¾¾çÇ¥Áö¹°Áú·Î¼ÀÇ È¿¿ë¼º. ´ëÇÑ»êºÎȸÁö 44: 121-127 (2001).
- ±Ç ¿ëÀÏ, ¹Ú ÅÂö, ¹Ú Á¾¼·, ¾ö ¼öÁ¾, ·ù ÀçÈ«, ÀÌ Áظð, ³²±Ã ¼ºÀº. Accelerated induction of dysplastic lesion by TPA in HPV 18 URR E6/E7 gene expressing transgenic mice. ´ëÇѾÏÇÐȸÁö 33: 56-63 (2001).
- Park JS, Kim EJ, Park TC, Kim EJ, Kim J, Lee JM, Namkoong SE, Um SJ. Growth Suppression of Ovarian Cancer Cells by Interferon-¥ã. ´ëÇѾÏÇÐȸÁö 33: 236-242 (2001).
- ¹Ú µ¿Ãá, ÃÖ ¾ç±Ô, ±è Áø¿ì, ¹Ú Á¾¼·, ±è ´ëÈÆ, ³²±Ã ¼ºÀº, ÀÌ Áظð. ¿©¼º È£¸£¸ó¿¡ ÀÇÇÑ »óÇǼº ³¼Ò¾Ï ¼¼Æ÷ÁÖÀÇ ¼ºÀå Á¶Àý. ´ëÇÑ»êºÎȸÁö 45: 408-416 (2002).
- ¹Ú Á¾¼·. ÀÎÀ¯µÎÁ¾ ¹ÙÀÌ·¯½º °¨¿°. ´ëÇÑÀÇ»çÇùȸÁö 45: 430-444 (2002).
- ÀÓ Ã¤Ãá, Ȳ ¼ºÁø, ¹Ú Á¾¼·, ³²±Ã ¼ºÀº. ¾Ï ¼ö¼ú½Ã sentinel lymph nodeÀÇ ÀÓ»óÀû À¯¿ë¼º. ´ëÇÑ»êºÎȸÁö 45: 940-945 (2002).
- ¸í Áø, ¶ó ¼±¿µ, ÀÌ ¸íÁø, ¾ö ¼öÁ¾, ³²±Ã ¼ºÀº, ¹Ú Á¾¼·. cDNA microarray¸¦ ÀÌ¿ëÇÑ HPV-16 E6¿Í ¿¬°üµÈ À¯ÀüÀÚÀÇ ¹ßÇö ºÐ¼®. ´ëÇÑ »êºÎȸÁö 45: 2183-2191 (2002).
- Lee SJ, Namkoong SE, Lee WC, Sul JW, Jee SH, You YK, Lee JE, Park JS. Polymorphisms of p53, p21, and IRF-1 and cervical cancer susceptibility in Korean Women. Cancer Res Treat 34: 357-364 (2002)
- ÀÌ ±ÙÈ£, ÀÓ Àº°æ, À± ÁÖÈñ, ¾ö ¼öÁ¾, ³²±Ã ¼ºÀº, ¹Ú Á¾¼·. Ursolic acid¿¡ ÀÇÇÑ ÀڱðæºÎ¾Ï ¼¼Æ÷ÁÖ¿¡¼ Ç×Áõ½Ä, Ç×¹ÙÀÌ·¯½º ÀÛ¿ë ±âÀü ºÐ¼®. ´ëÇѺÎÀÎÁ¾¾ç, ÄÝÆ÷ÇÐȸÁö 14. 306-314 (2003).
- ¹Ú ÅÂö, ±è ÂùÁÖ, ÀÌ ±ÙÈ£, À± ÁÖÈñ, ±è ÁöÈÆ, °í ¿µ¹Ì, ³²±Ã ¼ºÀº, ¹Ú Á¾¼·. HPV genotyping in Korean women with cervical neoplasia. ´ëÇÑ ºÎÀÎÁ¾¾çÄÝÆ÷ÇÐȸÁö 14; 40-48 (2003)
- Çã ¼ö¿µ, ÀÌ ¹é±Ç, À± ÁÖÈñ, ³²±Ã ¼ºÀº, ¹Ú Á¾¼·. ¿ÜÀ½ºÎ¾Ï ȯÀÚ¿¡¼ ±¤¹üÀ§ ¿ÜÀ½ºÎ ÀýÁ¦¼úÈÄ ´ëµÐ ±Ù¸·ÇǺΠµµ»ó °¨°¢ ÇÇÆÇÀ» ÀÌ¿ëÇÑ ¿ÜÀ½ºÎ Àç°Ç¼ú 1 ¿¹. ´ëÇÑ»êºÎȸÁö 46; 2047-2051 (2003)
- ¹Ú Á¾¼·. Àΰ£ À¯µÎÁ¾ ¹ÙÀÌ·¯½ºÀÇ »ý¹°ÇÐÀû Ư¼º°ú Á¾¾ç ¹ß»ý °úÁ¤¿¡ ´ëÇÑ ÀÌÇØ¿Í ÀÓ»óÀû Àû¿ë. ´ëÇѼ¼Æ÷º´¸®ÇÐȸÁö 15, 1-10 (2004)
- ±è ÂùÁÖ, ÀÓ Àº°æ, ÀÌ ±ÙÈ£, ³ë ´ö¿µ, ¹è ÁØ»ó, ³²±Ã ¼ºÀº, ¾ö ¼öÁ¾, ¹Ú Á¾¼·. ÀڱðæºÎ¾Ï ¼¼Æ÷ÁÖ¿¡¼ 5-fluorouracil Åõ¿©¿¡ ÀÇÇÑ Áõ½Ä ¾ïÁ¦ È¿°úÀÇ proteomic analysis. ´ëÇѺÎÀÎÁ¾¾ç, ÄÝÆ÷ÇÐȸÁö 14. 113-122 (2004)
- ±è ÇöÁ¤, Çã ¼ö¿µ, ±è ¹ÎÁ¤, ±è »çÁø, ±è ÀºÁß, ÀÌ ¿ø¼±, ¹Ú »óÈñ, ÀÌ ÈñÁø, ±è Áø¾Æ, ¹Ú Á¾¼·. ³¼Ò¾Ï¿¡¼ ÀÎü ¹éÇ÷±¸ Ç׿ø-GÀÇ ¹ßÇö ºÐ¼®. ´ëÇÑ»êºÎȸÁö 47, 2194-2203 (2004)
- ÃÖ ¹Ì³ª, ÀÌ ¿¬Á¤, Çã ¼ö¿µ, ±è ¹ÎÁ¤, ±ÇÀÎ, ±è »çÁø, ±è ÀºÁß, ±è Áø¾Æ, ¹Ú Á¾¼·, ¿ø¹ß¼º ³°üÀ¶¸ð»óÇÇ¾Ï 1 ¿¹. ´ëÇÑ»êºÎȸÁö 47, 2251-2254 (2004)
- ¼ °æÀ±, Çã ¼ö¿µ, ±è »çÁø, ¹Ú ÅÂö, ¹è ¼®³â, ÇÑ ±¸ÅÃ, ÀÌ Áظð, ³²±Ã ¼ºÀº, ¹Ú Á¾¼·. ³¼Ò ¹Ì¼º¼÷ ±âÇüÁ¾ÀÇ ÀÓ»óº´¸®ÇÐÀû °íÂû. ´ëÇÑ»êºÎȸÁö 47, 2389-2396 (2004)
- ÀÓ Àº°æ, ÀÌ ±ÙÈ£, ±è ÂùÁÖ, ³²±Ã ¼ºÀº, ¹Ú Á¾¼·. Proteome analysis of differential protein expression in cervical cancer cells after taxol treatment. Cancer Treat Res 36, 395-399 (2004)
- ÀÌ ±ÙÈ£, ÀÓ Àº°æ, À± ÁÖÈñ, ¾ö ¼öÁ¾, ³²±Ã ¼ºÀº, ¹Ú Á¾¼·. Ursolic acid¿¡ ÀÇÇÑ ÀڱðæºÎ¾Ï ¼¼Æ÷ÁÖ¿¡¼ Ç×Áõ½Ä, Ç×¹ÙÀÌ·¯½º ÀÛ¿ë ±âÀü ºÐ¼®. ´ëÇѺÎÀÎÁ¾¾ç, ÄÝÆ÷ÇÐȸÁö 14. 306-314 (2004).
|
|
|
±¹Á¦ ÇмúÁö ³í¹® ¹ßÇ¥
International Publications
|
|
|
- Um SJ, Kim EJ, Hwang ES, Kim SJ, Namkoong SE, Park JS. Antiproliferative effects of retinoid/interferon in cervical carcinoma cell lines: cooperative growth suppression of IRF-1 and p53. Int J Cancer 85: 416-423 (2000).
- Park JS, Kim EJ, Hwang ES, Namkoong SE, Um SJ. Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein: Implication of E7-mediated immune evade mechanism. J Biol Chem 275: 6764-6769 (2000).
- Kim CJ, Kim EJ, Um SJ, Park JS. Regulation of cell growth and HPV genes by exogenous estrogen. Int J Gynecol Cancer 10: 157-164 (2000).
- Moon MS, Lee CJ, Um SJ, Park JS, Yang JM, Hwang ES. Effect of BPV E2-mediated inhibition of E6/E7 expression in HPV-16-positive cervical carcinoma cells. Gynecol Oncol 80: 168-175 (2001).
- Park JS, Kim EJ, Lee JY, Sin HS, Namkoong SE, Um SJ. Functional inactivation of p73, a homologu of p53 tumor suppressor protein, by human papillomavirus E6 oncoprotein. Int J Cancer 91: 822-827 (2001).
- Um SJ, Kim EJ, Han HS, Park JS. Antiproliferative effects of retinoid derivatives in ovarian carcinoma cells. Cancer Letters, 174: 127-134 (2001).
- Um SJ, Rhyu JW, Kim EJ, Jeon KC, Hwang ES, Park JS. Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo. Cancer Letters 179: 205-212 (2002).
- Um SJ, Kim EJ, Lee SY, Myoung J, Park JS. Down-regulation of HPV E6/E7 oncogene by arsenic trioxide in cervical carcinoma cells. Cancer Letters 181: 11-22 (2002).
- Kim EJ, Lee JM, Namkoong SE, Um SJ, Park JS. Interferon-¥ã-mediated apoptosis in ovarian carcinoma through IRF-1. J Cell Biochem 85: 369-380 (2002).
- Lee CJ, Suh EJ, Kang HT, Im JS, Um SJ, Park JS, Hwang ES. Induction of senescent-like state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in cells immortalized by HPV 16 DNA. Exp Cell Res 15; 173-182 (2002)
- Kim EJ, Park JS, Um SJ. Identification and characterization of HIPK2 interaction with p73 and modulation functions of the p53 family in vivo. J Biol Chem 30; 32020-32028 (2002)
- Rhim CC, Park JS, Bae SN, Namkoong SE. Sentinel node biopsy as an indicator for pelvic node dissection in early stage cervical cancer. J Korean Med Sci 17; 507-511 (2002)
- Jee SH, Lee JE, Park JS. p53 codon-72 polymorphism and interaction with environmental factors in the development of cervical cancer. Int J Gynecol Obstet 80; 69-70 (2003)
- Kim CJ, Jeong JK, Park MS, Park TS, Namkoong SE, Park JS. HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions. Gynecol Oncol 89: 210-217 (2003)
- Kim EJ, Park CH, Park JS (Corresponding author), Um SJ. Functional dissection of the transactivation domain of interferon regulatory factor-1. Biochem Biophys Res Commun 2: 253-259 (2003)
- Park JS, Rhyu JW, Kim CJ, Kim HS, Lee SY, Kwon YI, Namkoong SE, Um SJ. Neoplastic change of squamo-columnar junction in uterine cervix and vaginal epithelium by exogenous estrogen in HPV-18 URR E6/E7 transgenic mice. Gynecol Oncol 89; 360-368 (2003)
- Kim SJ, Lee C, Lee SY, Kim Inho, Park JS, Sasagawa T, Ko JJ, Park JE, Oh YK. Enhanced immunogenicity of human papillomavirus 16 L1 genetic vaccines fused to an ER-targeting secretory signal peptide and RANTES. Gene Ther 10; 1268-1273 (2003)
- Kim EJ, Park JS (Corresponding author), Um SJ. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML. Nucleic Acids Res 15;31(18):5356-5367 (2003)
- Um SJ, Sin HS, Han HS, Kwon YJ, Kim EJ, Park SH, Kim SY, Bae TS, Park JS, Rho YS. Potent cytotoxic effects of novel retinamide derivatives in ovarian cancer cells. Biol Pharm Bull 26; 1412-1417 (2003)
- Um SJ, Han HS, Kwon YJ, Park SH, Rho YS, Sin HS, Park JS. Novel retinoic acid derivative ABPN has potent inhibitory activity on cell growth and apoptosis in cancer cells. Int J Cancer 20; 1038-1046 (2003)
- Lee JE, Lee SJ, Namkoong SE, Um SJ, Sull SW, Jee SH, You YK, Park JS. Gene-gene, gene-environmental interactions of IRF-1, p21 and p53 polymorphisms in Korean women with cervical cancer. Int J Gynecol Cancer 14; 118-125 (2004)
- Yim EK, Lee KH, Bae JS, Namkoong SE, Um SJ, Park JS. Proteomic analysis of antiproliferative effects by treatment of 5-fluorouracil in cervical cancer cells. DNA Cell Biol 23; 47-54 (2004)
- Park TC, Kim CJ, Lee KH, Yoon JH, Namkoong SE, Park JS. Human papillomavirus genotyping by the DNA chip in the cervical neoplasia. DNA Cell Biol 23; 119-125 (2004)
- Jee SH, Won SY, Yun JE. Park JS, Ji SS. Polymorphism p53 codon-72 and invasive cervical cancer: a meta analysis. Int J Gynecol Obstet 85; 301-308 (2004)
- Yim EK, Lee KH, Kim CJ, Namkoong SE, Um SJ, Park JS. Proteomic analysis of antiproliferative effects by treatment of 5-fluorouracil in cervical cancer cells. DNA Cell Biol, 23; 47-54 (2004)
- Yim EK, Meoyung J, Namkoong SE, Um SJ, Park JS. Genomic and proteomic patterns in HPV-16 E6 gene transfected stable human carcinoma cell lines. DNA Cell Biol 23; 826-835 (2004)
- Sull JW, Jee SH, Yi S, Lee JE, Park JS, Kim S, Ohrr H. The effect of methylenetetrahydropholate reductase polymorphism C677T on crevical cancer in Korean women. Gynecol Oncol 95; 557-563 (2004)
- Ho SH, Jee SH, Lee JE, Park JS. Analysis of risk factors for cervical cancer using induction technique. Expert Syst Appl, In press
|
|
|
Àú¼ú Ȱµ¿
|
|
|
- ±è ÁøÈ«, Á¶ÇöÈñ, ½ÅÁ¾Ã¶, ¹Ú Á¾¼·, ±è ÀºÁß. Áúȯº° »êºÎÀΰú ȯÀÚ °ü¸® Áöħ¼ 2005
|
|
|
³í¹® ¹ßÇ¥
Publications
|
|
|
|
|
|
|
´ëÇÑ»êºÎÀΰúÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
³¼Ò¾Ï¿¡¼ ÀÎü ¹éÇ÷±¸Ç׿ø-GÀÇ ¹ßÇö ºÐ¼®.
|
|
|
¿¬ ÀÚ : |
|
±èÇöÁ¤, Çã ¼ö ¿µ, ±è ¹Î Á¤, ±è»çÁø, ±èÀºÁß, ÀÌ¿ø¼±, ¹Ú»óÈñ, ÀÌÈñÁø, ±èÁø¾Æ,
¹Ú Á¾ ¼· |
|
|
vol : |
|
47±Ç 11È£ 2194~203 |
|
|
|
|
|
|
|
´ëÇÑ»êºÎÀΰúÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
³¼ÒÀ§Ã¼ °æ°è¼º Àå¾×¼º ³¶¼±¾ÏÁ¾ 1¿¹.
|
|
|
¿¬ ÀÚ : |
|
Á¤¹®¿µ, ¼°æÀ±, ±è Áø ÈÖ, ÀÌ¿¬Á¤, ±è ¹Î Á¤, Çã ¼ö ¿µ, ±è»çÁø, ±èÀºÁß, ±èÁø¾Æ,
¹Ú Á¾ ¼· |
|
|
vol : |
|
47±Ç 12È£ 2485~9. |
|
|
|
|
|
|
|
´ëÇÑ»êºÎÀΰúÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
¿ø¹ß¼º ³°üÀ¶¸ð»óÇÇ¾Ï 1¿¹
|
|
|
¿¬ ÀÚ : |
|
Ãֹ̳ª, ÀÌ¿¬Á¤, Çã ¼ö ¿µ, ±è ¹Î Á¤, ±ÇÀÎ, ±è»çÁø, ±èÀºÁß, ±èÁø¾Æ, ¹Ú Á¾ ¼· |
|
|
vol : |
|
Vol. 47(11) |
|
|
|
|
|
|
|
´ëÇÑ»êºÎÀΰúÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
³¼Ò¾Ï¿¡¼ ÀÎü ¹éÇ÷±¸ Ç׿ø-GÀÇ ¹ßÇö ºÐ¼®
|
|
|
¿¬ ÀÚ : |
|
±èÇöÁ¤, Çã ¼ö ¿µ, , ±è»çÁø, ±èÀºÁß, ÀÌ¿ø¼±, ¹Ú»óÈñ, ÀÌÈñÁø, ±èÁø¾Æ, ¹Ú Á¾ ¼· |
|
|
vol : |
|
Vol. 47(11)"
"36 |
|
|
|
|
|
|
|
´ëÇÑ»êºÎÀΰúÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
³¼Ò ¹Ì¼º¼÷ ±âÇüÁ¾ÀÇ ÀÓ»óº´¸®ÇÐÀû °íÂû
|
|
|
¿¬ ÀÚ : |
|
¼°æÀ±, Çã ¼ö ¿µ, ±è»çÁø, ¹ÚÅÂö, ¹è ¼® ³â, Çѱ¸ÅÃ, ÀÌ ÁØ ¸ð, ³² ±Ã ¼º Àº, ¹Ú Á¾ ¼· |
|
|
vol : |
|
Vol. 47(12) |
|
|
|
|
|
|
|
´ëÇÑ»êºÎÀΰúÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
¿ø¹ß¼º º¹¸· Àå¾×¼º À¯µÎ»ó ¾ÏÁ¾ 1¿¹
|
|
|
¿¬ ÀÚ : |
|
õ¼ÒÈñ, ÀÌ¿¬Á¤, Çã ¼ö ¿µ, ±ÇÀÎ, ±è»çÁø, ±èÀºÁß, ±èÁø¾Æ, ³² ±Ã ¼º Àº, ¹Ú Á¾ ¼· |
|
|
vol : |
|
Vol. 47(7) |
|
|
|
|
|
|
|
´ëÇѺÎÀÎÁ¾¾ç.ÄÝÆ÷½ºÄÚÇÇÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
Ursolic acid¿¡ ÀÇÇÑ ÀڱðæºÎ¾Ï ¼¼Æ÷ÁÖ¿¡¼ Ç×Áõ½Ä, Ç×¹ÙÀÌ·¯½º ÀÛ¿ë ±âÀü ºÐ¼®
|
|
|
¿¬ ÀÚ : |
|
ÀÌ ±Ù È£, ÀÓÀº°æ, À±ÁÖÈñ, ¾ö¼öÁ¾, ³² ±Ã ¼º Àº, ¹Ú Á¾ ¼· |
|
|
vol : |
|
14(4). 306-314 |
|
|
|
|
|
|
|
´ëÇѺÎÀÎÁ¾¾ç.ÄÝÆ÷½ºÄÚÇÇÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
ÀڱðæºÎ¾Ï ¼¼Æ÷ÁÖ¿¡¼ 5-fluorouracil Åõ¿©¿¡ ÀÇÇÑ Áõ½Ä ¾ïÁ¦ È¿°úÀÇ Proteomic analysis
|
|
|
¿¬ ÀÚ : |
|
±èÂùÁÖ, ÀÓÀº°æ, ÀÌ ±Ù È£, ³ë´ö¿µ, ¹èÁØ»ó, ¹ÚÅÂö, ³² ±Ã ¼º Àº, ¾ö¼öÁ¾, ¹Ú Á¾ ¼· |
|
|
vol : |
|
vol. 15(2) |
|
|
|
|
|
|
|
´ëÇѺÎÀÎÁ¾¾ç.ÄÝÆ÷½ºÄÚÇÇÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
¿ÜÀ½ºÎ¾Ï¿¡ ´ëÇÑ ÀÓ»óº´¸®ÇÐÀû ¿¬±¸
|
|
|
¿¬ ÀÚ : |
|
ÀÌÇØ³², ÀÌ ±Ù È£, ±èÂùÁÖ, ¹Ú Á¾ ¼·, ³² ±Ã ¼º Àº |
|
|
vol : |
|
vol. 15(3) |
|
|
|
|
|
|
|
´ëÇѺÎÀÎÁ¾¾ç.ÄÝÆ÷½ºÄÚÇÇÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
A Clinicopathologic Study of Vulva Cancer
|
|
|
¿¬ ÀÚ : |
|
Hae Nam Lee, Keun Ho Lee, Chung won Lee, Chan Joo Kim, Jong Sup Park, Sung-Eun Namkoong |
|
|
vol : |
|
Vol. 15, No. 3, |
|
|
|
|
|
|
|
´ëÇÑ ¾Ï ÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
Proteome anlaysis of differential protein expression in cervical cancer cells after taxol treatment
|
|
|
¿¬ ÀÚ : |
|
¹Ú Á¾ ¼· |
|
|
vol : |
|
12¿ùÈ£,2004 |
|
|
|
|
|
|
|
´ëÇѼ¼Æ÷º´¸®ÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
Àΰ£ À¯µÎÁ¾ ¹ÙÀÌ·¯½ºÀÇ »ý¹°ÇÐÀû Ư¼º°ú Á¾¾ç¹ß»ý°úÁ¤¿¡ ´ëÇÑ ÀÌÇØ¿Í ÀÓ»óÀû Àû¿ë
|
|
|
¿¬ ÀÚ : |
|
¹Ú Á¾ ¼· |
|
|
vol : |
|
vol. 15(1) |
|
|
|
|
|
|
|
´ëÇÑ»êºÎÀΰúÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
ÀڱðæºÎ¾Ï ¹ß»ý ¿äÀΰú BARD-1 (BRCA-associated ring domain-1) À¯ÀüÀÚ SNPÀÇ »óÈ£ ÀÛ¿ë.
|
|
|
¿¬ ÀÚ : |
|
±è ÁøÈÖ, ÀÌ ¼ºÁ¾, ÀÌ ±Ù È£, ±è ÂùÁÖ, ³² ±Ã ¼º Àº, ¹Ú Á¾ ¼· |
|
|
vol : |
|
48, 1698-1707 |
|
|
|
|
|
|
|
´ëÇѺÎÀÎÁ¾¾ç.ÄÝÆ÷½ºÄÚÇÇÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
ÀڱðæºÎ¾Ï ¼¼Æ÷ÁÖ¿¡¼ Paclitaxel Ç×¾Ï Ä¡·á¿Í °ü·ÃµÈ »õ·Î¿î Ç¥Àû ´Ü¹éÁú TACC3 (Transforming acidic coiled coil 3)ÀÇ µ¿Á¤.
|
|
|
¿¬ ÀÚ : |
|
ÀÓ Àº°æ, ÀÌ ±Ù È£, ÀÌ ÈñÁ¤, ±è ÂùÁÖ, ¹Ú ÅÂö, ¾ö ¼öÁ¾, ¹Ú Á¾ ¼· |
|
|
vol : |
|
16, 229-241 |
|
|
|
|
|
|
|
´ëÇѺÎÀÎÁ¾¾ç.ÄÝÆ÷½ºÄÚÇÇÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
Ä¡·áÀû HPV DNA ¹é½Å °³¹ßÀ» À§ÇÑ ¸ðµ¨; DNAÀÇ °æÇÇÀû Åõ¿©¹ý¿¡ ÀÇÇÑ ¼¼Æ÷¸é¿ª ¹ÝÀÀÀÇ Áõ°¡.
|
|
|
¿¬ ÀÚ : |
|
±è ÂùÁÖ, ÀÓ Àº°æ, ÀÌ ÇØ³², ÀÌ ±Ù È£, ¹Ú ÅÂö, ³² ±Ã ¼º Àº, ¹Ú Á¾ ¼· |
|
|
vol : |
|
16, 242-255 |
|
|
|
|
|
|
|
´ëÇѺÎÀÎÁ¾¾ç.ÄÝÆ÷½ºÄÚÇÇÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
Etoposide 󸮿¡ ÀÇÇÑ CaSki ÀڱðæºÎ¾Ï ¼¼Æ÷¿¡¼ ´Ü¹éÁú ¹ßÇö ¾ç»ó.
|
|
|
¿¬ ÀÚ : |
|
ÀÌ ½Â¹é, ÀÓ Àº°æ, ±è ÂùÁÖ, ÀÌ ±Ù È£, ¹Ú Á¾ ¼· |
|
|
vol : |
|
in press |
|
|
|
|
|
|
|
Cancer Research And Treatment
|
|
|
¿¬ Á¦ : |
|
The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis.
|
|
|
¿¬ ÀÚ : |
|
Yim EK, Jong Sup Park |
|
|
vol : |
|
in press |
|
|
|
|
|
|
|
Gynecologic Oncology
|
|
|
¿¬ Á¦ : |
|
Proteomic analysis of anticancer effect of paclitaxel in cervical cancer cells.
|
|
|
¿¬ ÀÚ : |
|
Lee KH, Yim EK, Kim CJ, Sung-Eun Namkoong, Um SJ, Jong Sup Park |
|
|
vol : |
|
98; 45-53 |
|
|
|
|
|
|
|
Oncology Reports
|
|
|
¿¬ Á¦ : |
|
Sequence variation and the transcriptional activity of the upstream regulatory region in human papillomavirus 16 E7 variations in cervical cancer in Korean women.
|
|
|
¿¬ ÀÚ : |
|
Kim YB, Song YS, Jeon YT, Jong Sup Park, Um SJ, Kim JW, Park NH, Kang SB, Lee HP. |
|
|
vol : |
|
14; 459-464 |
|
|
|
|
|
|
|
Int J Gynecol Cancer
|
|
|
¿¬ Á¦ : |
|
Analysis of differential protein expression by cisplatin treatment in cervical carcinoma cells.
|
|
|
¿¬ ÀÚ : |
|
Yim EK, Lee KH, Kim CJ, Jong Sup Park |
|
|
vol : |
|
in press |
|
|
|
|
|
|
|
Int J Gynecol Cancer
|
|
|
¿¬ Á¦ : |
|
Analysis of in vitro synergistic effect of 5-fluorouracil and cisplatin on cervical carcinoma cells.
|
|
|
¿¬ ÀÚ : |
|
Yim EK, Lee SB, Lee KH, Kim CJ, Jong Sup Park |
|
|
vol : |
|
in press |
|
|
|
|
|
|
|
ºÐÀÚÀÓ»óÀÇÇÐ
|
|
|
¿¬ Á¦ : |
|
HPV E6, E7 ¹ß¾Ï ´Ü¹éÁú°ú ¿¬°üµÈ ÀڱðæºÎ¾ÏÀÇ ¹ß»ý ±âÀü.
|
|
|
¿¬ ÀÚ : |
|
¹Ú Á¾ ¼· |
|
|
vol : |
|
|
|
|
|
|
|
|
|
Expert Syst Appl
|
|
|
¿¬ Á¦ : |
|
Analysis of risk factors for cervical cancer using induction technique.
|
|
|
¿¬ ÀÚ : |
|
Ho SH, Jee SH, Lee JE, ¹Ú Á¾ ¼· |
|
|
vol : |
|
in press |
|
|
|
|
|
|
|
Cancer Lett
|
|
|
¿¬ Á¦ : |
|
Proteomic analysis of ursolic acid-induced apoptosis in cervical carcinoma cells.
|
|
|
¿¬ ÀÚ : |
|
Yim EK, Lee KH, Sung-Eun Namkoong, Um SJ, Jong Sup Park |
|
|
vol : |
|
in press |
|
|
|
|
|
|
|
´ëÇÑ»êºÎÀΰúÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
ÀڱðæºÎ¼±¾ÏÀÇ ÀÓ»óº´¸®ÇÐÀû Ư¡°ú ¿¹ÈÄÀÎÀÚ
|
|
|
¿¬ ÀÚ : |
|
ÀÌÇØ³², ±èÂùÁÖ, ÃÖÁ¤¼ö, ¹Ú Á¾ ¼·, ³² ±Ã ¼º Àº |
|
|
vol : |
|
49(4) 866-873 |
|
|
|
|
|
|
|
´ëÇÑ»êºÎÀΰúÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
µ¿½Ã¿¡ ¹ß°ßµÈ ¿ø¹ß¼º ºÎÀξϿ¡ ´ëÇÑ ÀÓ»óÀû ºÐ¼®
|
|
|
¿¬ ÀÚ : |
|
µ¿ ¼ ¿¬, ÀÌ ¿ë ¼®, ¹Ú Á¾ ¼·, ÀÌ ÁØ ¸ð, ³² ±Ã ¼º Àº |
|
|
vol : |
|
49(9) 1902-1907 |
|
|
|
|
|
|
|
´ëÇÑ»êºÎÀΰúÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
³¼Ò ±âÇüÁ¾ ¼ö¼ú Àü ¹Ì¼º¼÷ ±âÇüÁ¾À» °¨º°Çϱâ À§ÇÑ ÀÚ±â°ø¸í ¿µ»ó ¼Ò°ß
|
|
|
¿¬ ÀÚ : |
|
ÃÖÁÖÇõ, µ¿ ¼ ¿¬, ±è¹ÎÁ¤, ¹Ú Á¾ ¼·, ÀÓ ¿ë ÅÃ, ±èÁøÈ«, ³ª¼ºÀº, ±è ¹Ì ¶õ |
|
|
vol : |
|
49, 1547-1553 |
|
|
|
|
|
|
|
´ëÇѺÎÀÎÁ¾¾ç.ÄÝÆ÷½ºÄÚÇÇÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
ÀڱðæºÎ¾Ï ȯÀÚÀÇ ¸²ÇÁÀý ÀüÀÌ¿Í Àç¹ßÀÇ ¿¹Ãø¿¡ ÀÖ¾î¼ Sentinel Node HPV StatusÀÇ ÀÇÀÇ
|
|
|
¿¬ ÀÚ : |
|
ÀÌ ¿ë ¼®, ÀÓäÃá, ÀÌÇØ³², ÀÌ ±Ù È£, ¹è ¼® ³â, ¹Ú Á¾ ¼·, ³² ±Ã ¼º Àº |
|
|
vol : |
|
17 (2) 112-120 |
|
|
|
|
|
|
|
´ëÇѺÎÀÎÁ¾¾ç.ÄÝÆ÷½ºÄÚÇÇÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
ÀڱðæºÎ¾Ï ¼¼Æ÷ÁÖ¿¡¼ etoposide Ç×¾Ï Ä¡·á¿¡ ÀÇÇÑ ¼¼Æ÷ »ç¸ê ±âÀü: ¼¼Æ÷ ÀÚ¸ê»ç (apoptosis)¿Í ºñ¼¼Æ÷ ÀÚ¸ê»ç¿¡ ÀÇÇÑ ¼¼Æ÷ »ç¸ê.
|
|
|
¿¬ ÀÚ : |
|
µ¿ ¼ ¿¬, À̽¹é, ±èÁ¤Áø, ¹Ú Á¾ ¼· |
|
|
vol : |
|
17, 188-199 |
|
|
|
|
|
|
|
´ëÇѺÎÀÎÁ¾¾ç.ÄÝÆ÷½ºÄÚÇÇÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
ÀڱðæºÎ¾Ï ¿¹¹æ ¹é½ÅÀÇ ÇöȲ°ú Àü¸Á.
|
|
|
¿¬ ÀÚ : |
|
¹Ú Á¾ ¼· |
|
|
vol : |
|
17±Ç4È£ |
|
|
|
|
|
|
|
Int J Gynecol Cancer
|
|
|
¿¬ Á¦ : |
|
Analysis of in vitro synergistic effect of 5-fluorouracil and cisplatin on cervical carcinoma cells.
|
|
|
¿¬ ÀÚ : |
|
Yim EK, Lee SB, Lee KH, Kim CJ, Jong Sup Park |
|
|
vol : |
|
16, 1321-1329 |
|
|
|
|
|
|
|
Int J Gynecol Cancer
|
|
|
¿¬ Á¦ : |
|
Analysis of differential protein expression by cisplatin treatment in cervical carcinoma cells.
|
|
|
¿¬ ÀÚ : |
|
Yim EK, Lee KH, Kim CJ, Jong Sup Park |
|
|
vol : |
|
16, 690-697 |
|
|
|
|
|
|
|
Int J Gynecol Cancer
|
|
|
¿¬ Á¦ : |
|
Antiproliferative and antiviral mechanism of ursolic acid and dexamethasone in cervical carcinoma cells.
|
|
|
¿¬ ÀÚ : |
|
Yim EK, Lee KH, Kim CJ, Jong Sup Park |
|
|
vol : |
|
in press |
|
|
|
|
|
|
|
Int J Gynecol Cancer
|
|
|
¿¬ Á¦ : |
|
Persistence of human papillomavirus (HPV) as a predictor for treatment failure after loop electrosurgical excision procedure (LEEP)
|
|
|
¿¬ ÀÚ : |
|
Jeong Hoon Bae, Kim Chan Joo, Park Tae Chu, Jong Sup Park |
|
|
vol : |
|
Submitted |
|
|
|
|
|
|
|
Cancer Lett
|
|
|
¿¬ Á¦ : |
|
Proteomic analysis of ursolic acid-induced apoptosis in cervical carcinoma cells.
|
|
|
¿¬ ÀÚ : |
|
Yim EK, Lee KH, Sung-Eun Namkoong, Um SJ, Jong Sup Park |
|
|
vol : |
|
2006 Apr 28 235(2):209-20 |
|
|
|
|
|
|
|
Eur J Obstet Gynecol Reprod Biol
|
|
|
¿¬ Á¦ : |
|
Clinical analysis of synchronous primary neoplasms of the female reproductive tract.
|
|
|
¿¬ ÀÚ : |
|
Tong SY, Yong- Seok Lee, Jong Sup Park, Bae SN, Joon-Mo Lee, Sung-Eun Namkoong |
|
|
vol : |
|
2006 Oct 16 |
|
|
|
|
|
|
|
Eur J Obstet Gynecol Reprod Biol
|
|
|
¿¬ Á¦ : |
|
Clinical analysis of synchronous primary neoplasms of the female reproductive tract.
|
|
|
¿¬ ÀÚ : |
|
Tong SY, Yong- Seok Lee, Jong Sup Park, Bae SN, Joon-Mo Lee, Sung-Eun Namkoong |
|
|
vol : |
|
Oct. 16, [Epud ahead of print] |
|
|
|
|
|
|
|
Exp Rev Proteomics
|
|
|
¿¬ Á¦ : |
|
Role of proteomics in translational research in cervical cancer.
|
|
|
¿¬ ÀÚ : |
|
Yim EK, Jong Sup Park |
|
|
vol : |
|
3, 21-36 |
|
|
|
|
|
|
|
Exp Rev Proteomics
|
|
|
¿¬ Á¦ : |
|
Role of proteomics in translational research in cervical cancer.
|
|
|
¿¬ ÀÚ : |
|
Yim EK, Jong Sup Park |
|
|
vol : |
|
3, 21-36 |
|
|
|
|
|
|
|
Immunol Lett
|
|
|
¿¬ Á¦ : |
|
Enhancement of dendritic cell-based vaccine potency by targeting antigen to endosomal/lysosomal compartments.
|
|
|
¿¬ ÀÚ : |
|
Kang TH, Lee JH, Bae HC, Noh KH, Kim JH, Sonh CK, Shin BC, Hung C-F, Wu TC, Jong Sup Park(Co-coresponding author), Kim TW |
|
|
vol : |
|
106, 126-134 |
|
|
|
|
|
|
|
´ëÇÑ»êºÎÀΰúÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
Prognostic outcomes of patient¡¯s with clinical stage I ? II endometrial cancer according to bilateral salpingo-oophorectomy
|
|
|
¿¬ ÀÚ : |
|
Han Chan Hee, Si Yeon Lim, Ill Young Kook, Keun Ho Lee,Sung-Eun Namkoong, Jong Sup Park |
|
|
vol : |
|
50(2), 288-94 |
|
|
|
|
|
|
|
´ëÇÑ»êºÎÀΰúÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
ÀڱðæºÎ¾Ï ¼¼Æ÷ÁÖ¿¡¼ Camptothecan °è ½Å Ç×¾ÏÁ¦ BelotecanÀÇ ¼¼Æ÷ Áõ½Ä ¾ïÁ¦ È¿°ú.
|
|
|
¿¬ ÀÚ : |
|
Àü û¶ó, ÀÌ ±Ù È£, ¿À Àº°æ, ±è ÂùÁÖ, ¹Ú ÅÂö, ¹Ú Á¾ ¼· |
|
|
vol : |
|
50, 1233-1240 |
|
|
|
|
|
|
|
´ëÇÑ»êºÎÀΰúÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
ÀÓ»óÀû º´±â I-II Àڱ󻸷¾Ï ȯÀÚÀÇ º´±â ¼³Á¤ ¼ö¼ú½Ã ³°ü ³¼Ò ÀýÁ¦¼ú À¯¹«¿¡ µû¸¥ ¿¹ÈÄÀÇ ºñ±³. ´ëÇÑ »êºÎȸÁö
|
|
|
¿¬ ÀÚ : |
|
ÇÑ Âù Èñ, ÀÓ ½Ã¿¬, ±¹ ÀÏ¿µ, ÀÌ ±Ù È£, ³² ±Ã ¼º Àº, ¹Ú Á¾ ¼· |
|
|
vol : |
|
50, 288-294 |
|
|
|
|
|
|
|
´ëÇÑ»êºÎÀΰúÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
6 ¼¼ ¿©¾ÆÀÇ ÀڱðæºÎ Åõ¸í¼¼Æ÷¾Ï 1 ¿¹.
|
|
|
¿¬ ÀÚ : |
|
¹® Á¤¹Î, ÀÌ ¾Æ¿ø, µ¿ ¼ ¿¬, ÀÌ ¿ë ¼®, ±è ¹Ì ¶õ, ¹Ú Á¾ ¼·, ³² ±Ã ¼º Àº |
|
|
vol : |
|
50, 366-371 |
|
|
|
|
|
|
|
´ëÇÑ»êºÎÀΰúÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
HPV E6 ¹ß¾Ï ´Ü¹éÁú°ú °áÇÕÇÏ´Â CDD7 ´Ü¹éÀÇ ±â´É ºÐ¼®.
|
|
|
¿¬ ÀÚ : |
|
µ¿ ¼ ¿¬, ±è Á¤Áø, Á¶ ¾ç¼÷, ¹Ú Á¾ ¼· |
|
|
vol : |
|
50, 459-464 |
|
|
|
|
|
|
|
´ëÇÑ»êºÎÀΰúÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
±¹¼ÒÀû µµÆ÷¹ýÀ» ÀÌ¿ëÇÑ Hair-follicle specific promoter¸¦ °¡Áø HPV-16 E7 DNA vaccineÀÇ È¿¿ë¼º.
|
|
|
¿¬ ÀÚ : |
|
±è ÂùÁÖ, ±è Å¿ì, ³ë °æÈñ, ÀÌ ±Ù È£, ÀÌ ÇØ³², ÀÌ ¿ë ¼®, ¹Ú ÅÂö, ³² ±Ã ¼º Àº, ¹Ú Á¾ ¼· |
|
|
vol : |
|
50, 512-522 |
|
|
|
|
|
|
|
´ëÇÑ»êºÎÀΰúÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
Áõ·Êº¸°í: º¹°°æ ¼ö¼úÀ» ÀÌ¿ëÇÑ ´ë¸Á ³¶Á¾ÀÇ Ä¡·á.
|
|
|
¿¬ ÀÚ : |
|
¹è Á¤ ÈÆ, ÀÌ ¼º Á¾, ÀÌ ¿ë ¼®, ¹Ú Á¾ ¼· |
|
|
vol : |
|
50, in press |
|
|
|
|
|
|
|
´ëÇѺÎÀÎÁ¾¾ç.ÄÝÆ÷½ºÄÚÇÇÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
Çѱ¹ ÀڱðæºÎ¾Ï ¿©¼º¿¡¼ÀÇ Ras Association Domain Family 1A (RASSF1A) Ala133Ser À¯ÀüÀÚ´ÙÇü¼º ¿¬±¸.
|
|
|
¿¬ ÀÚ : |
|
ÀÌ ±Ù È£, ¼³ Àç¿õ, ¹Ú Á¤¿ë, À± ÁöÀº, ½Å ÇØ¸², ¿À ÇØÃ¶, ÀÌ Á¾Àº, ±è ÂùÁÖ, Áö ¼±ÇÏ, ¹Ú Á¾ ¼· |
|
|
vol : |
|
18, 1-7 |
|
|
|
|
|
|
|
´ëÇѺÎÀÎÁ¾¾ç.ÄÝÆ÷½ºÄÚÇÇÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
Çѱ¹ ÀþÀº ¿©¼ºÀÇ ¼º»ýȰ ¾ç»ó; HPV ¿¹¹æ ¹é½Å µµÀÔÀ» À§ÇÑ ¿¹ºñ ¿¬±¸.
|
|
|
¿¬ ÀÚ : |
|
±è ÂùÁÖ, ±è º´±â, ±è ½Âö, ±è ¿µÅÂ, ±è ¿ë¸¸, ¹Ú »óÀ±, ¼Û ¿ë»ó, ÀÌ ³«¿ì, ÀÌ ¿øÃ¶, ÀÌ Àç°ü, Á¶ Ä¡Èì, Çã ¼ö ¿µ,¹Ú Á¾ ¼·(Ã¥ÀÓÀúÀÚ), ÀÌ ±Ô¿Ï |
|
|
vol : |
|
18, 209-218 |
|
|
|
|
|
|
|
´ëÇѺÎÀÎÁ¾¾ç.ÄÝÆ÷½ºÄÚÇÇÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
HPV-°ü·Ã¼º ÀڱðæºÎ º´º¯¿¡¼ HPV °¨¿°¿¡ ´ëÇÑ pH/¿Âµµ °¨ÀÀ¼º ºÐ»ç Á¦À縦 ÀÌ¿ëÇÑ ±¹¼Ò Ä¡·á¹ý °³¹ß.
|
|
|
¿¬ ÀÚ : |
|
±è ÂùÁÖ, Á¤ º´¹®, ±è Å¿ì, ° ÅÂÈ«, ³ë °æÈñ, ±è ¸í¿Á, ·ù Àç¿õ, ±è Èñ¼÷, ¹Ú Á¾ ¼· |
|
|
vol : |
|
18, in press |
|
|
|
|
|
|
|
´ëÇѺÎÀÎÁ¾¾ç.ÄÝÆ÷½ºÄÚÇÇÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
´ëÇѺÎÀÎÁ¾¾ç¤ýÄÝÆ÷½ºÄÚÇÇÇÐȸÀÇ 4°¡ ÀÎÀ¯µÎÁ¾ ¹ÙÀÌ·¯½º ¹é½Å Á¢Á¾ ±Ç°í¾È
|
|
|
¿¬ ÀÚ : |
|
±èº´±â, À̳«¿ì, ±è½Âö, ±è¿µÅÂ, ±è¿ë¸¸, ±èÂùÁÖ, ¹Ú»óÀ±, ¼Û¿ë»ó, ÀÌÀç°ü, ÀÌ¿øÃ¶, Á¶³²ÈÆ, Á¶Ä¡Èì, Çã ¼ö ¿µ, ¹Ú Á¾ ¼·, À̱ԿÏ. |
|
|
vol : |
|
18±Ç 4È£ 259~283 |
|
|
|
|
|
|
|
DNA and Cell Biology
|
|
|
¿¬ Á¦ : |
|
Caspase-independent autophagic cytotoxicity in etoposide-treated CaSki cervical carcinoma cells.
|
|
|
¿¬ ÀÚ : |
|
Lee SB, Kim JJ, Tong SY, Jong Sup Park |
|
|
vol : |
|
26: 713-720 |
|
|
|
|
|
|
|
DNA and Cell Biology
|
|
|
¿¬ Á¦ : |
|
Novel interaction between HPV E6 and BARD1 (BRCA1-associated ring domain 1) and its biologic roles.
|
|
|
¿¬ ÀÚ : |
|
Yim EK, Tong SY, MJ, Jong Sup Park |
|
|
vol : |
|
26: 753-761 |
|
|
|
|
|
|
|
Gynecologic Oncology
|
|
|
¿¬ Á¦ : |
|
HPV status in sentinel nodes might be a prognostic factor in cervical cancer.
|
|
|
¿¬ ÀÚ : |
|
Lee YS, Rhim CC, Lee HN, Lee KH, Jong Sup Park, Sung-Eun Namkoong |
|
|
vol : |
|
105, 351-357 |
|
|
|
|
|
|
|
Int J Gynecol Cancer
|
|
|
¿¬ Á¦ : |
|
Human papillomavirus type distribution in women from Asia: a meta-analysis.
|
|
|
¿¬ ÀÚ : |
|
Bao YP, Smith JS, Qiao YL, ACCPAB members (Jong Sup Park) |
|
|
vol : |
|
17, 1-9 |
|
|
|
|
|
|
|
Int J Gynecol Cancer
|
|
|
¿¬ Á¦ : |
|
Persistence of human papillomavirus (HPV) as a predictor for treatment failure after loop electrosurgical excision procedure (LEEP).
|
|
|
¿¬ ÀÚ : |
|
Bae JH, Kim CJ, Sung-Eun Namkoong, Jong Sup Park |
|
|
vol : |
|
17: 1271-1277 |
|
|
|
|
|
|
|
Int J Gynecol Cancer
|
|
|
¿¬ Á¦ : |
|
Human papillomavirus genotype as a prognostic factor in carcinoma of the uterine cervix.
|
|
|
¿¬ ÀÚ : |
|
Tong SY, Yong- Seok Lee, Jong Sup Park, Sung-Eun Namkoong |
|
|
vol : |
|
17: 1307-1313 |
|
|
|
|
|
|
|
J Microbiol Biotechn
|
|
|
¿¬ Á¦ : |
|
Human papillomavirus (HPV) type distribution in Korean women: a meta-analysis.
|
|
|
¿¬ ÀÚ : |
|
Bae JH, Lee SJ, Kim CJ, Hur SY, Park YK, Lee WC, Kim YT, Ng TL, Bock HL, Jong Sup Park |
|
|
vol : |
|
in press |
|
|
|
|
|
|
|
Woman's Wells
|
|
|
¿¬ Á¦ : |
|
ÀڱðæºÎ¾Ï ¿¹¹æ 4 °¡ ¹é½Å °¡´Ù½Ç.
|
|
|
¿¬ ÀÚ : |
|
¹Ú Á¾ ¼· |
|
|
vol : |
|
10, 86-91 |
|
|
|
|
|
|
|
Biomarker Insights
|
|
|
¿¬ Á¦ : |
|
Biomarkers in cervical cancer.
|
|
|
¿¬ ÀÚ : |
|
Yim EK, Jong Sup Park |
|
|
vol : |
|
2, 215-225 |
|
|
|
|
|
|
|
Biochem Biophys Res Commun
|
|
|
¿¬ Á¦ : |
|
Filamin A negatively regulates the transcriptional activity of p73 alpha in the cytoplasm.
|
|
|
¿¬ ÀÚ : |
|
Kim EJ, Jong Sup Park, Um SJ. |
|
|
vol : |
|
Nov 3;362(4):1101-6. Epub 2007 Aug 31 |
|
|
|
|
|
|
|
Expert Opi Med Diag
|
|
|
¿¬ Á¦ : |
|
Emerging biomarkers in the detection, diagnosis and management of cervical dysplasia and carcinoma.
|
|
|
¿¬ ÀÚ : |
|
Bae JH, Jong Sup Park |
|
|
vol : |
|
in press |
|
|
|
|
|
|
|
´ëÇÑ»êºÎÀΰúÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
º¹°°æ¼ö¼úÀ» ÀÌ¿ëÇÑ ´ë¸Á ³¶Á¾ÀÇ Ä¡·á
|
|
|
¿¬ ÀÚ : |
|
¹è Á¤ ÈÆ, ¼Û·Ï, ÀÌ ¿ë ¼®, ±è ¹Ì ¶õ, ¹Ú Á¾ ¼· |
|
|
vol : |
|
51, 2 247-251 |
|
|
|
|
|
|
|
´ëÇѺÎÀÎÁ¾¾ç.ÄÝÆ÷½ºÄÚÇÇÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
Àڱà °æºÎ¾Ï ¸ðµ¨¿¡¼ PEG/PLLA copolymer systemÀ» »ç¿ëÇÑ Paclitaxel ±¹¼Ò Åõ¿©ÀÇ È¿°ú
|
|
|
¿¬ ÀÚ : |
|
±èÂùÁÖ, ÀÌ ¿ë ¼®,ÀÌ ±Ù È£,Á¤º´¹®,±èÅ¿ì,°ÅÂÈï,±èÈñ¼÷, ¹Ú Á¾ ¼· |
|
|
vol : |
|
19, 1 68-74 |
|
|
|
|
|
|
|
´ëÇѺÎÀÎÁ¾¾ç.ÄÝÆ÷½ºÄÚÇÇÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
A case of unknown origin inguinal lymph node squamous cell carcinoma, accompanied with carcinoma in situ of cervix.
|
|
|
¿¬ ÀÚ : |
|
ÀÌ ¼º ÇÏ, ±è ¹Î Á¤,ÀÌÈñÁ¤,±è»çÁø,
¹Ú Á¾ ¼·, Çã ¼ö ¿µ |
|
|
vol : |
|
19, 2 1-7 |
|
|
|
|
|
|
|
´ëÇѼ¼Æ÷º´¸®ÇÐȸÁö
|
|
|
¿¬ Á¦ : |
|
Áú È®´ë°æ»ó ºñÁ¤»ó ¼Ò°ßÀ» º¸ÀΠȯÀÚ¿¡¼ HPV DNA chip°ú Hybrid-Capture II assayÀÇ ÀÓ»óÀû À¯¿ë¼º
|
|
|
¿¬ ÀÚ : |
|
±èÅÂÁ¤,Á¤Âù±Ç,À̾ƿø,Á¤Àº¼±,ÃÖ¿µÁø,À̱³¿µ, ¹Ú Á¾ ¼· |
|
|
vol : |
|
19, 2 119-125 |
|
|
|
|
|
|
|
Eur J Obstet Gynecol Reprod Biol
|
|
|
¿¬ Á¦ : |
|
Clinical analysis of synchronous primary neoplasms of the female reproductive tract
|
|
|
¿¬ ÀÚ : |
|
µ¿ ¼ ¿¬, ÀÌ ¿ë ¼®, ¹Ú Á¾ ¼·, ¹è ¼® ³â, ÀÌ ÁØ ¸ð, ³² ±Ã ¼º Àº |
|
|
vol : |
|
136, 1 78-82 |
|
|
|
|
|
|
|
J Microbiol Biotechn
|
|
|
¿¬ Á¦ : |
|
Human Papillomavirus Type Distribution in Korean Women: A Meta-Analysis
|
|
|
¿¬ ÀÚ : |
|
¹è Á¤ ÈÆ, ÀÌ ¼º Á¾,±èÂùÁÖ,
Çã ¼ö ¿µ,¹Ú¿ë±Ô,ÀÌ¿øÃ¶,±è¿µÅ¹,Timothy L. Ng,Hans L. Bock,¹Ú Á¾ ¼· |
|
|
vol : |
|
18, 4 788-794 |
|
|
|
|
|
|
|
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY
|
|
|
¿¬ Á¦ : |
|
Duplicated uterine arteries in laparoscopic hysterectomy
|
|
|
¿¬ ÀÚ : |
|
ÀÌ ±Ù È£,¹ÚÅÂö,¹Ú Á¾ ¼· |
|
|
vol : |
|
15, 1 3-3 |
|
|
|
|
|
|
|
J Gynecol Oncol
|
|
|
¿¬ Á¦ : |
|
A case of inguinal lymph node squamous cell carcinoma of unknown origin, accompanied with carcinoma in situ of cervix
|
|
|
¿¬ ÀÚ : |
|
Lee Sung-Ha, MinJung KIM, Lee HJ, Kim SJ, Jong Sup Park, Soo Young Hur |
|
|
vol : |
|
19(2) 145~149 |
|
|
|
|
|
¿¬±¸ °úÁ¦
|
|
|
|
|
 |
|
¿©¼º¾ÏÀÇ ÀüÀÌ °ü·Ã À¯ÀüÀÚ Å½»ö ¹× ±â´ÉºÐ¼® |
|
|
¿¬±¸±â°ü : |
|
SRC ¿¬±¸°úÁ¦ (¿¬¼¼´ëÇб³ ¾ÏÀüÀÌ ¿¬±¸¼¾ÅÍ) |
|
|
¿¬±¸ºñ : |
|
25,000,000¿ø |
|
|
¼¼ºÎ¿¬±¸Ã¥ÀÓÀÚ : |
|
¹Ú Á¾ ¼·
(ÁÖ°ü: ³ë Àç°æ)
|
|
|
¿¬±¸±â°£ : |
|
2000-2008 |
|
|
|
|
|
 |
|
ºÎÀÎ¾Ï ¹ß¾Ï ±âÀü ±Ô¸í ¹× ½Å Ä¡·á¹ý °³¹ß ¿¬±¸ |
|
|
¿¬±¸±â°ü : |
|
º¸°ÇÀÇ·á±â¼ú¿¬±¸°³¹ß»ç¾÷ ÁßÁ¡°øµ¿Áö¿ø¿¬±¸°³¹ß»ç¾÷(º¸°Çº¹ÁöºÎ) |
|
|
¿¬±¸ºñ : |
|
600,000,000¸¸¿ø |
|
|
ÁÖ°ü¿¬±¸Ã¥ÀÓÀÚ : |
|
¹Ú Á¾ ¼·
|
|
|
¿¬±¸±â°£ : |
|
2004 |
|
|
|
|
|
 |
|
Functional study for cervical carcinogenesis-related genes |
|
|
¿¬±¸±â°ü : |
|
KISTEP Project |
|
|
¿¬±¸ºñ : |
|
|
|
|
ÁÖ°ü¿¬±¸Ã¥ÀÓÀÚ : |
|
¹Ú Á¾ ¼·
|
|
|
¿¬±¸±â°£ : |
|
|
|
|
|
|
|
 |
|
Functional study for genomes relating female cancer metastasis |
|
|
¿¬±¸±â°ü : |
|
Cancer Metastasis Research Center Project |
|
|
¿¬±¸ºñ : |
|
|
|
|
ÁÖ°ü¿¬±¸Ã¥ÀÓÀÚ : |
|
¹Ú Á¾ ¼·
|
|
|
¿¬±¸±â°£ : |
|
|
|
|
|
|
|
 |
|
Study for HPV genome and SNP in Korean women with cervical cancer |
|
|
¿¬±¸±â°ü : |
|
21C Frontier Human Genome Functional Research Project |
|
|
¿¬±¸ºñ : |
|
|
|
|
ÁÖ°ü¿¬±¸Ã¥ÀÓÀÚ : |
|
¹Ú Á¾ ¼·
|
|
|
¿¬±¸±â°£ : |
|
|
|
|
|
|
|
 |
|
ÀÎÀ¯µÎÁ¾ ¹ÙÀÌ·¯½º E6, E7 ¹ß¾Ï ´Ü¹éÁú¿¡ ÀÇÇÏ¿© Á¶ÀýµÇ´Â ÀڱðæºÎ¾Ï ¿¬°ü ´Ü¹éÁú Ž»ö°ú ±â´É ±Ô¸í |
|
|
¿¬±¸±â°ü : |
|
ÇмúÁøÈïÀç´Ü ¼±µµ¿¬±¸ÀÚ °³¹ß°úÁ¦ |
|
|
¿¬±¸ºñ : |
|
5,000 ¸¸¿ø |
|
|
ÁÖ°ü¿¬±¸Ã¥ÀÓÀÚ : |
|
¹Ú Á¾ ¼·
|
|
|
¿¬±¸±â°£ : |
|
|
|
|
|
|
|
 |
|
Investigation of carcinogenesis and development of new therapeutic modalities in gynecological cancers |
|
|
¿¬±¸±â°ü : |
|
Ministry of Health & Social Walfare Project |
|
|
¿¬±¸ºñ : |
|
|
|
|
ÁÖ°ü¿¬±¸Ã¥ÀÓÀÚ : |
|
¹Ú Á¾ ¼·
|
|
|
¿¬±¸±â°£ : |
|
|
|
|
|
|
|
 |
|
Proteomics in the disease model using HPV E6, E7 |
|
|
¿¬±¸±â°ü : |
|
POSCO Project |
|
|
¿¬±¸ºñ : |
|
|
|
|
ÁÖ°ü¿¬±¸Ã¥ÀÓÀÚ : |
|
¹Ú Á¾ ¼·
|
|
|
¿¬±¸±â°£ : |
|
|
|
|
|
|
|
 |
|
¿©¼º¾Ï ÀüÀÌ¿Í ¿¬°üµÈ À¯Àüü º¯ÈÀÇ ±â´ÉÀû Æò°¡ |
|
|
¿¬±¸±â°ü : |
|
°¡Å縯´ëÇб³(º»ºÎ) |
|
|
¿¬±¸ºñ : |
|
|
|
|
ÁÖ°ü¿¬±¸Ã¥ÀÓÀÚ : |
|
¹Ú Á¾ ¼·
|
|
|
¿¬±¸±â°£ : |
|
2006 |
|
|
|
|
|
 |
|
HPV E6 ´Ü¹éÁú°ú ¹ÝÀÀÇÏ´Â ½Å±Ô ´Ü¹éÁúµéÀÇ »ý¹°ÇÐÀû ¿ªÇÒ ±Ô¸í ¹× ÀÓ»óÀû Àû¿ë |
|
|
¿¬±¸±â°ü : |
|
º¸°Ç»ê¾÷ÁøÈï¿ø |
|
|
¿¬±¸ºñ : |
|
55,000,000 |
|
|
ÁÖ°ü¿¬±¸Ã¥ÀÓÀÚ : |
|
¹Ú Á¾ ¼·
|
|
|
¿¬±¸±â°£ : |
|
2006/05/01~2007/03/31 |
|
|
|
|
|
 |
|
2007³â ¿ë¿ª¿¬±¸ |
|
|
¿¬±¸±â°ü : |
|
½ÄǰÀǾàǰ¾ÈÀüû |
|
|
¿¬±¸ºñ : |
|
|
|
|
ÁÖ°ü¿¬±¸Ã¥ÀÓÀÚ : |
|
¹Ú Á¾ ¼·
|
|
|
¿¬±¸±â°£ : |
|
2007-01-25~ |
|
|
|
|
|
 |
|
2007³â ¾ÏÁ¤º¹ÃßÁø°³¹ß»ç¾÷ |
|
|
¿¬±¸±â°ü : |
|
±¹¸³¾Ï¼¾ÅÍ |
|
|
¿¬±¸ºñ : |
|
|
|
|
ÁÖ°ü¿¬±¸Ã¥ÀÓÀÚ : |
|
¹Ú Á¾ ¼·
|
|
|
¿¬±¸±â°£ : |
|
2007-02-28 |
|
|
|
|
|
 |
|
¹Ì·¡º¸°Ç±â¼ú°³¹ß»ç¾÷ |
|
|
¿¬±¸±â°ü : |
|
Çѱ¹º¸°Ç»ê¾÷ÁøÈï¿ø |
|
|
¿¬±¸ºñ : |
|
|
|
|
ÁÖ°ü¿¬±¸Ã¥ÀÓÀÚ : |
|
¹Ú Á¾ ¼·
|
|
|
¿¬±¸±â°£ : |
|
2007-04-01 |
|
|
|
|
|
 |
|
HPV E6 ´Ü¹éÁú°ú ¹ÝÀÀÇÏ´Â ½Å±Ô ´Ü¹éÁúµéÀÇ »ý¹°ÇÐÀû ¿ªÇÒ ±Ô¸í ¹× ÀÓ»óÀû Àû¿ë 2007³â »ó¹Ý±â º¸°ÇÀÇ·á±â¼ú°³¹ß»ç¾÷ |
|
|
¿¬±¸±â°ü : |
|
º¸°Ç»ê¾÷ÁøÈï¿ø |
|
|
¿¬±¸ºñ : |
|
|
|
|
ÁÖ°ü¿¬±¸Ã¥ÀÓÀÚ : |
|
¹Ú Á¾ ¼·
, ¹èÁ¤ÈÆ,µ¿¼¿¬,À̱ÙÈ£,±èÂùÁÖ,À̿뼮,ÀÓÀº°æ,È£Àº¹Ì,ÀÌÀçÀº,À¯Á¤È
|
|
|
¿¬±¸±â°£ : |
|
2007-06-11~ |
|
|
|
|
|
 |
|
HPV °¨¿°°ú ¿¬°üµÈ ÀڱðæºÎÁ¾¾ç ½ÇÇè¸ðµ¨¿¡¼ÀÇ Ä¡·á¹é½Å Æò°¡ ¹× ÀÓ»óÀû Àû¿ë 2007³â ¾ÏÁ¤º¹ÃßÁø»ç¾÷ |
|
|
¿¬±¸±â°ü : |
|
±¹¸³¾Ï¼¾ÅÍ |
|
|
¿¬±¸ºñ : |
|
|
|
|
ÁÖ°ü¿¬±¸Ã¥ÀÓÀÚ : |
|
¹Ú Á¾ ¼·
,±èÂùÁÖ,Çã¼ö¿µ,¹èÁ¤ÈÆ,µ¿¼¿¬,È£Àº¹Ì,ÀÌÀçÀº,À¯Á¤È
|
|
|
¿¬±¸±â°£ : |
|
2007-10-16~ |
|
|
|
|
|
|
 |
|
|